Inventor · disambiguated record
Beatrice Cameron
Also filed as: CAMERON BEATRICE · CAMERON BÉATRICE
47 granted patents·23 pending applications·498 citations·filing 1993–2025
98Inventor score
Top patents by PatentIndex Score
70 records- 0195US11530268B2Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infectionSANOFI SA·Filed 2019·Granted Dec 20, 2022·15 cites·34 claims
- 0295US11365261B2Anti-CD38 antibodies and methods of useSANOFI SA·Filed 2021·Granted Jun 21, 2022·3 cites·29 claims
- 0395US9617345B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2015·Granted Apr 11, 2017·53 cites·20 claims
- 0495US8614299B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideBAURIN NICOLAS·Filed 2010·Granted Dec 24, 2013·56 cites·27 claims
- 0594US11613576B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2020·Granted Mar 28, 2023·3 cites·29 claims
- 0694US11186649B2Anti-CD38 antibodies and methods of useSANOFI SA·Filed 2018·Granted Nov 30, 2021·10 cites·41 claims
- 0791US11332542B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2019·Granted May 17, 2022·4 cites·11 claims
- 0888US6537793B2Method of separating viral particlesAVENTIS PHARMA SA·Filed 2001·Granted Mar 25, 2003·44 cites·14 claims
- 0987US10457739B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2017·Granted Oct 29, 2019·6 cites·40 claims
- 1087US9493529B2Robo1-Fc fusion protein and use thereof for treating tumoursBLANCHE FRANCIS·Filed 2011·Granted Nov 15, 2016·20 cites·11 claims
- 1187US8119770B2Modified soluble FGF receptor Fc fusions with improved biological activityBLANCHE FRANCIS·Filed 2007·Granted Feb 21, 2012·19 cites·20 claims
- 1287US6492164B1Circular DNA expression cassettes for gene transferAVENTIS PHARMA SA·Filed 2000·Granted Dec 10, 2002·17 cites·10 claims
- 1386US7038026B2Purification of a triple heli formation with an immobilized oligonucleotideCENTELION·Filed 2001·Granted May 2, 2006·10 cites·33 claims
- 1484US8647622B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useLEE RENATA·Filed 2008·Granted Feb 11, 2014·9 cites·9 claims
- 1583US8852593B2Antagonist antibodies and their fab fragments against GPVI and uses thereofBAURIN NICOLAS·Filed 2010·Granted Oct 7, 2014·8 cites·8 claims
- 1682US12227573B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2023·Granted Feb 18, 2025·0 cites·45 claims
- 1782US6143530ACircular DNA expression cassettes for in vivo gene transferRHONE POULENC RORER SA·Filed 1996·Granted Nov 7, 2000·71 cites·43 claims
- 1880US10112991B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2016·Granted Oct 30, 2018·2 cites·30 claims
- 1979US6825012B2DNA molecules, preparation and use in gene therapyGENCELL SA·Filed 2001·Granted Nov 30, 2004·5 cites·30 claims
- 2078US8017744B2Purification of a triple helix formation with an immobilized oligonucleotideCENTELION·Filed 2009·Granted Sep 13, 2011·1 cites·6 claims
- 2176US9382312B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2013·Granted Jul 5, 2016·2 cites·26 claims
- 2276US2022073629A1Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their UsesSANOFI SA·Filed 2021·Application pending·0 cites
- 2374US6410273B1Method for producing methylated DNAAVENTIS PHARMA SA·Filed 1997·Granted Jun 25, 2002·28 cites·15 claims
- 2473US6207150B1Variants of thymidine kinase, nucleic acids encoding them, and methods of using themAVENTIS PHARMA SA·Filed 1997·Granted Mar 27, 2001·32 cites·37 claims
- 2572US2023357401A1Trispecific anti-cd38, anti-cd28, and anti-cd3 binding proteins and methods of use for treating viral infectionSANOFI SA·Filed 2022·Application pending·0 cites
- 2672US2022275102A1Anti-cd38 antibodies and methods of useSANOFI SA·Filed 2022·Application pending·0 cites
- 2771US8980262B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useSANOFI SA·Filed 2013·Granted Mar 17, 2015·1 cites·23 claims
- 2871US2025250337A1Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2025·Application pending·0 cites
- 2965US2023416395A1Anti-cd38 antibodies and formulationsSANOFI SA·Filed 2023·Application pending·0 cites
- 3064US6319672B1Purification of a triple helix formation with an immobilized oligonucleotideAVENTIS PHARMA SA·Filed 2000·Granted Nov 20, 2001·16 cites·21 claims
- 3163US2024226314A1Transferrin receptor binding proteinsSANOFI SA·Filed 2023·Application pending·0 cites
- 3262US9809653B2Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereofSANOFI SA·Filed 2015·Granted Nov 7, 2017·1 cites·17 claims
- 3362US2024262923A1Anti-pd-1×4-1bb binding proteinsGENZYME CORP·Filed 2023·Application pending·0 cites
- 3462US2018100019A1Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their UseSANOFI SA·Filed 2018·Application pending·0 cites
- 3560US9243067B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useSANOFI SA·Filed 2013·Granted Jan 26, 2016·0 cites·9 claims
- 3660US9234039B2Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the sameCORVEY CARSTEN·Filed 2011·Granted Jan 12, 2016·1 cites·17 claims
- 3760US9228019B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useSANOFI SA·Filed 2013·Granted Jan 5, 2016·0 cites·9 claims
- 3860US9175087B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useSANOFI SA·Filed 2013·Granted Nov 3, 2015·0 cites·11 claims
- 3960US8399636B2Purification of a triple helix formation with an immobilized obligonucleotideCROUZET JOEL·Filed 2011·Granted Mar 19, 2013·0 cites·16 claims
- 4060US2019119365A1Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2018·Application pending·0 cites
- 4159US9815902B2Humanized anti-CXCR5 antibodies, derivatives thereof and their usesSANOFI SA·Filed 2016·Granted Nov 14, 2017·0 cites·8 claims
- 4259US2003104444A1Circular DNA expression cassettes for gene transferAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 4358US11655302B2Anti-CD38 antibodies and formulationsSANOFI SA·Filed 2020·Granted May 23, 2023·0 cites·24 claims
- 4458US7514218B2Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interactionCENTELION·Filed 2006·Granted Apr 7, 2009·0 cites·17 claims
- 4558US7052838B2Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interactionCENTELION·Filed 2002·Granted May 30, 2006·0 cites·30 claims
- 4658US2004077005A1Novel topoisomerase IV, corresponding nucleotide sequences and uses thereofAVENTIS PHARMA SA·Filed 2003·Application pending·0 cites
- 4757US9441040B2Antagonist antibodies and their fab fragments against GPVI and uses thereofSANOFI SA·Filed 2014·Granted Sep 13, 2016·0 cites·15 claims
- 4857US2006019352A1Methods of increasing the production of cobalamins using cob gene expressionAVENTIS PHARMA SA·Filed 2003·Application pending·0 cites
- 4955US2002187527A1Method for producing therapeutic DNAFiled 2001·Application pending·0 cites
- 5052US8481487B2Modified soluble FGF receptor Fc fusions methodBLANCHE FRANCIS·Filed 2012·Granted Jul 9, 2013·0 cites·26 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Beatrice Cameron files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →